Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum (COVID-Preg)
Sponsor: Barcelona Institute for Global Health
A PHASE3 clinical study on COVID and Covid-19, this trial is completed. The trial is conducted by Barcelona Institute for Global Health and has accumulated 8 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Feb 2022 — Jul 2024 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Oct 2021 — Feb 2022 [monthly]
Recruiting PHASE3
▶ Show 3 earlier versions
-
Feb 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE3
First recorded
May 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Barcelona Institute for Global Health
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Fundación de investigación HM
- Hospital Clinic of Barcelona
- Hospital General de Segovia
- Hospital Sant Joan de Deu
- Hospital Universitario Fundación Alcorcón
- Hospital Universitario Infanta Leonor
- Hospital del Mar
- Institut Català de la Salut
- University Hospital of Torrejon
For direct contact, visit the study record on ClinicalTrials.gov .